Learn smart, effective strategies for managing anxiety, depression, feelings of isolation, and more.

Thyroid eye disease is a chronic autoimmune disorder that inflames tissues behind the eye. Swelling can cause dry, irritated eyes, bulging, light sensitivity, and double vision. Thyroid eye disease ...

Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first FDA-authorized protein-splicing therapy SB-007 in phase 1/2 testing. Encelto, an ...

Dry eye has emerged as an early warning sign of autoimmune disease, appearing roughly three years before many patients receive a formal diagnosis. That gap reframes a common irritation as a potential ...

A panelist discusses how dry eye disease involves tear film imbalance, leading to inflammation and ocular surface damage, emphasizing the importance of precise diagnosis and tailored treatment while ...

Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy.

“Over the past few years, with the advent of pharmaceutical therapy for thyroid eye disease, it’s a little more in the forefront. With the marketing and ads on TV, it’s become more commonly discussed, ...

Doses of Tepezza are given by an intravenous infusion through a blood vessel in your arm. This infusion is usually given at a hospital, health care provider’s office, or infusion center. Sometimes you ...

CHICAGO — Endocrinologists should consider ways to refine their in-clinic eye exams for patients with thyroid eye disease, including testing for color vision, visual acuity, pupillary reaction, and ...

MFDS IND approval enables a multicenter, randomized, double-blind, vehicle-controlled phase 2 study in ~150 DED patients, randomized 1:1:1 to two dosing arms versus control over 12 weeks. Prior phase ...

What to know about medical treatments, lifestyle adjustments, and more to navigate life with TED.

Dry eye disease affects many people across different autoimmune diseases, ranging in prevalence from about 23% to 81%, and appears about 3 years before diagnosis, a study finds.